Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
07/1996
07/16/1996US5536752 Phenyl heterocycles as COX-2 inhibitors
07/16/1996US5536736 Triazolyl-phenoxyacetic acid compounds which have useful pharmaceutical utility
07/16/1996US5536718 Tricyclic benzazepine vasopressin antagonists
07/16/1996US5536641 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1 and uses thereof for detection of, and isolation of, vascular endothelial cells
07/11/1996WO1996021035A2 Retroviral delivery of full length factor viii
07/11/1996WO1996021016A2 New staphylokinase derivatives
07/11/1996WO1996020955A1 Purified thrombopoietin and method of making it
07/11/1996WO1996020936A1 Novel thiazolidin-4-one derivatives
07/11/1996WO1996020719A2 Body fluid replacement solution
07/11/1996WO1996020718A2 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
07/11/1996WO1996015758A3 Methods for stimulating erythropoiesis using thrombopoietin
07/11/1996CA2209619A1 Thrombolytic agents
07/11/1996CA2207577A1 Purified thrombopoietin and method of making it
07/11/1996CA2206479A1 New staphylokinase derivatives
07/11/1996CA2184174A1 Novel thiazolidin-4-one derivatives
07/10/1996EP0720620A1 Glutathione analogs and paralog panels comprising glutathione mimics
07/10/1996EP0720599A1 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
07/10/1996CN1126470A Pyridazinone derivatives with pharmaceutical activity
07/09/1996US5534503 2'-O, N6 -disubstituted and 2'-O, N6, 2-trisubstituted adenosines and their medicinal uses
07/09/1996US5534268 Liposomes containing bioavailable iron (II) and process for obtaining them
07/04/1996WO1996020192A1 Piperidineacetic acid derivatives useful as fibrinogen antagonist agent
07/04/1996WO1996020173A1 Piperazine derivatives, medicaments containing the same, their use and process for preparing the same
07/04/1996WO1996020172A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED β-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
07/04/1996WO1996019999A1 Thrombolytic enzyme and method of obtaining same
07/04/1996WO1996019965A2 Engraftment of hematopoietic cells from a primate donor to a primate recipient
07/04/1996DE4447599A1 Use of racemic or enantiomeric alpha liponic acid and derivs
07/04/1996CA2208719A1 Engraftment of hematopoietic cells from a primate donor to a primate recipient
07/04/1996CA2207618A1 Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation
07/03/1996EP0719791A2 Medicaments for the treatment of restenosis and arterial sclerosis
07/03/1996EP0719775A1 Substituted 4-phenyl thiazole derivatives, process for their preparation and pharmaceutical compositions containing them
07/03/1996EP0719334A1 Pharmaceutical compositions containing ecotin and homologs thereof
07/03/1996EP0719284A1 Improvements in or relating to haemoglobin
07/03/1996EP0719154A1 Activated factor viii as a therapeutic agent and method of treating factor viii deficiency
07/03/1996CN1125952A Process for manufacture of 1-deamino-8-D-arginine vasopressin
07/03/1996CN1125944A Phenyl heterocycles as cyclooxygenase-2 inhibitors
07/03/1996CN1125717A Cyclohexadiene derivatives
07/03/1996CN1125617A Medicine for treatment of aplastic anemia and its preparation method
07/03/1996CN1125575A Adhesion receptor antagonists
07/02/1996US5532366 Enzyme inhibitors
07/02/1996US5532352 Chemically modifying hemoglobin for use in a blood substitute
07/02/1996US5532269 Administering thioctic acid or derivatives; vasodilation; side effect reduction
07/02/1996US5532266 Treatment of hypoxia, antiedemic agents or antiinflammatory agents
07/02/1996US5532255 Anticoagulants, cardiovascular disorders, antiinflammatory agents, arteriosclerosis or antitumor agents
07/02/1996US5532253 Enzyme inhibitors as anticoagulants
07/02/1996US5532235 Tricyclic benzazepine vasopressin antagonists
07/02/1996US5532233 Platelet activating factor antagonist
07/02/1996US5532232 Inhibit thrombin induced platelet aggregation; fibrinogen anticoagulants in blood
06/1996
06/29/1996CA2166165A1 Substituted 4-phenylthiazole derivatives, process for their preparation and pharmaceutical compositions containing them
06/27/1996WO1996019493A1 N-SUBSTITUTED GLYCINE DERIVATIVES AS INHIBITORS OF FACTOR Xa
06/27/1996WO1996019491A1 Heterocyclic keto arginine peptides as thrombin inhibitors
06/27/1996WO1996019483A1 Low molecular weight bicyclic thrombin inhibitors
06/27/1996WO1996019475A1 Fibrinogen receptor antagonists
06/27/1996WO1996019223A1 Fibrinogen receptor antagonists
06/27/1996WO1996019222A1 Fibrinogen receptor antagonists
06/27/1996CA2208773A1 Heterocyclic keto arginine peptides as thrombin inhibitors
06/27/1996CA2208772A1 Low molecular weight bicyclic thrombin inhibitors
06/26/1996EP0718307A2 Derivatives of 1-oxo-2-(phenylsulfonyl-amino)-pentylpiperidine, their preparation and therapeutic use
06/26/1996EP0718287A2 Piperazine derivatives, medicaments containing them, their use, and processes for their preparation
06/26/1996CN1125479A Ligands for FLT3 receptors
06/26/1996CN1125450A Factor VII-derived peptides
06/26/1996CN1125449A Sialyl Lex analogues as inhibitors of cellular adhesion
06/26/1996CN1125401A Erythropoietin analog compositions and methods
06/26/1996CN1032142C Expression of factor seventh and ninth activities in mammalian cells
06/25/1996US5530118 Phospholipase inhibitor
06/25/1996US5530014 Cyclohexadiene derivatives
06/25/1996US5529996 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
06/25/1996US5529995 Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase and ACE
06/24/1996CA2166032A1 1-oxo-2-(phenylsulfonylamino)pentylpiperidine; process for preparing them and their use as therapeutic agents
06/24/1996CA2165922A1 Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation
06/20/1996WO1996018654A1 Factor vii fragment 82-128 and its use in blood-clotting disorders
06/20/1996WO1996018653A1 Disulphide-cyclo-[h-cys-glu-gln-tyr-cys-oh], and its use in blood-clotting disorders
06/20/1996WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
06/20/1996WO1996018644A1 Aromatic heterocyclic derivatives as enzyme inhibitors
06/20/1996WO1996018639A1 Novel protein tyrosine kinase, jak3
06/20/1996WO1996018602A1 Bicyclic fibrinogen antagonists
06/20/1996WO1996018418A1 Improved adenoviral vectors and producer cells
06/20/1996WO1996018393A1 Novel compounds
06/20/1996CA2207626A1 Novel protein tyrosine kinase, jak3
06/20/1996CA2206683A1 Improved adenoviral vectors and producer cells
06/20/1996CA2206400A1 Aromatic heterocyclic derivatives as enzyme inhibitors
06/20/1996CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling
06/19/1996EP0717044A1 Thienopyridone derivatives, their preparation and their use as NMDA-receptor antagonists
06/19/1996EP0716857A1 Use of rapamycin for treating anemia
06/19/1996EP0716607A1 Biochemically balanced peritoneal dialysis solutions
06/19/1996EP0505452B1 Use of inositolphosphates for preparing medicament
06/19/1996CN1124964A Trifunctional antithrombin and antiplatelet peptides
06/19/1996CN1124960A Indole derivatives as 5-HT1A and/or 5-HT2 ligands
06/19/1996CN1124957A 1-amidinophenyl-pyrrolidones piperidinones azetinones as platelet aggregation inhibitors
06/19/1996CN1124652A Chinese herbal medicine for curing aplastic anemia
06/18/1996CA1338401C Anticoagulant polypeptide
06/16/1996CA2165129A1 Thienopyridones
06/14/1996CA2164921A1 Method of treating anemia
06/13/1996WO1996017953A2 Genetic basis of factor xiii activity
06/13/1996WO1996017860A1 New dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals
06/13/1996WO1996017833A1 Bicyclic fibrinogen antagonists
06/13/1996WO1996017827A1 PROCESS FOR THE PREPARATION OF AMIDINO PHENYL PYRROLIDINE β-ALANINE UREA ANALOGS
06/13/1996WO1996011021A3 Treatment of tissues to reduce subsequent response to injury
06/13/1996DE4443390A1 Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten New dipeptide p-Amidinobenzylamide with N-terminal sulfonyl or Aminosulfonylresten
06/13/1996CA2207874A1 Novel dipeptide p-amidinobenzylamides with n-terminal sulfonyl or aminosulfonyl radicals
06/12/1996EP0715633A1 Haemopoietic growth factor antagonists
1 ... 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 ... 671